APA

Dabrowska A., Library of Congress, . (2018). FDA Risk Evaluation and Mitigation Strategies (REMS): description and effect on generic drug development. [Washington, D.C.]: Congressional Research Service.

Chicago

Dabrowska Agata, Library of Congress, . 2018. FDA Risk Evaluation and Mitigation Strategies (REMS): description and effect on generic drug development. [Washington, D.C.]: Congressional Research Service.

Harvard

Dabrowska A., Library of Congress, . (2018). FDA Risk Evaluation and Mitigation Strategies (REMS): description and effect on generic drug development. [Washington, D.C.]: Congressional Research Service.

MLA

Dabrowska Agata, Library of Congress, . FDA Risk Evaluation and Mitigation Strategies (REMS): description and effect on generic drug development. [Washington, D.C.]: Congressional Research Service. 2018.